Title : Doxycycline potentiates antitumor effect of cyclophosphamide in mice.

Pub. Date : 2005 Feb 1

PMID : 15667832






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX. Cyclophosphamide transformation related protein 53, pseudogene Mus musculus
2 Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX. Cyclophosphamide transformation related protein 53, pseudogene Mus musculus
3 Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX. Cyclophosphamide transformation related protein 53, pseudogene Mus musculus
4 Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX. Cyclophosphamide transformation related protein 53, pseudogene Mus musculus
5 Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX. Cyclophosphamide transformation related protein 53, pseudogene Mus musculus
6 Additional analyses indicate that the tumor suppressor p53 and p53-regulated proapoptotic Bax were upregulated in vivo and in vitro following CPA treatment in combination with DOX, suggesting that upregulation of p53 may contribute to the enhancement of antitumor effect of CPA by DOX. Cyclophosphamide transformation related protein 53, pseudogene Mus musculus